Concepts (223)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Peanut Hypersensitivity | 8 | 2023 | 15 | 3.010 |
Why?
|
| Food Hypersensitivity | 9 | 2023 | 63 | 2.490 |
Why?
|
| Asthma | 12 | 2022 | 955 | 2.360 |
Why?
|
| Desensitization, Immunologic | 9 | 2023 | 36 | 2.240 |
Why?
|
| Tobacco Smoke Pollution | 4 | 2016 | 23 | 2.030 |
Why?
|
| Arachis | 6 | 2023 | 10 | 1.800 |
Why?
|
| Dust | 4 | 2017 | 26 | 1.710 |
Why?
|
| Environmental Exposure | 6 | 2017 | 296 | 1.130 |
Why?
|
| Allergens | 10 | 2023 | 179 | 1.100 |
Why?
|
| Anaphylaxis | 2 | 2023 | 33 | 1.030 |
Why?
|
| Hypersensitivity | 4 | 2021 | 154 | 1.020 |
Why?
|
| Immunologic Deficiency Syndromes | 2 | 2022 | 47 | 1.000 |
Why?
|
| Hypersensitivity, Immediate | 3 | 2013 | 62 | 0.900 |
Why?
|
| Egg Hypersensitivity | 2 | 2019 | 4 | 0.840 |
Why?
|
| Housing | 5 | 2015 | 42 | 0.820 |
Why?
|
| Allergy and Immunology | 1 | 2019 | 12 | 0.720 |
Why?
|
| Child | 21 | 2022 | 6927 | 0.720 |
Why?
|
| Child, Preschool | 16 | 2023 | 3612 | 0.660 |
Why?
|
| Poverty | 3 | 2016 | 173 | 0.630 |
Why?
|
| Emergency Service, Hospital | 3 | 2021 | 484 | 0.630 |
Why?
|
| 2S Albumins, Plant | 1 | 2017 | 1 | 0.610 |
Why?
|
| Antigens, Plant | 1 | 2017 | 14 | 0.610 |
Why?
|
| Periodicals as Topic | 1 | 2019 | 168 | 0.610 |
Why?
|
| Environmental Monitoring | 3 | 2014 | 71 | 0.580 |
Why?
|
| Glycoproteins | 2 | 2017 | 234 | 0.570 |
Why?
|
| Microbiota | 2 | 2018 | 381 | 0.550 |
Why?
|
| Pandemics | 2 | 2021 | 740 | 0.550 |
Why?
|
| Pediatrics | 1 | 2019 | 344 | 0.530 |
Why?
|
| Pyroglyphidae | 2 | 2013 | 14 | 0.490 |
Why?
|
| Eczema | 1 | 2014 | 7 | 0.490 |
Why?
|
| Humans | 45 | 2023 | 86644 | 0.490 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2014 | 51 | 0.470 |
Why?
|
| Dietary Supplements | 1 | 2014 | 128 | 0.450 |
Why?
|
| Rhinitis, Allergic, Perennial | 1 | 2013 | 81 | 0.450 |
Why?
|
| Dermatitis, Atopic | 2 | 2023 | 52 | 0.420 |
Why?
|
| Air Pollution, Indoor | 4 | 2014 | 63 | 0.420 |
Why?
|
| Angioedema | 1 | 2011 | 4 | 0.410 |
Why?
|
| Bacteria | 1 | 2015 | 447 | 0.410 |
Why?
|
| Familial Mediterranean Fever | 1 | 2010 | 4 | 0.390 |
Why?
|
| Cryopyrin-Associated Periodic Syndromes | 1 | 2010 | 2 | 0.390 |
Why?
|
| Stomatitis, Aphthous | 1 | 2010 | 4 | 0.390 |
Why?
|
| Pharyngitis | 1 | 2010 | 16 | 0.390 |
Why?
|
| Models, Theoretical | 1 | 2012 | 482 | 0.360 |
Why?
|
| Smoking | 1 | 2013 | 609 | 0.350 |
Why?
|
| Administration, Oral | 5 | 2022 | 684 | 0.350 |
Why?
|
| Medicaid | 2 | 2022 | 217 | 0.330 |
Why?
|
| Retrospective Studies | 6 | 2022 | 8489 | 0.290 |
Why?
|
| United States | 10 | 2023 | 6672 | 0.290 |
Why?
|
| Rhinitis, Allergic | 2 | 2019 | 43 | 0.290 |
Why?
|
| Immune Tolerance | 2 | 2019 | 337 | 0.270 |
Why?
|
| Female | 18 | 2021 | 44533 | 0.270 |
Why?
|
| Epinephrine | 2 | 2021 | 84 | 0.250 |
Why?
|
| Food Supply | 2 | 2021 | 28 | 0.250 |
Why?
|
| Air Microbiology | 2 | 2014 | 5 | 0.230 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 1621 | 0.230 |
Why?
|
| Double-Blind Method | 3 | 2022 | 1823 | 0.220 |
Why?
|
| Fungi | 2 | 2014 | 65 | 0.220 |
Why?
|
| Skin Tests | 1 | 2022 | 44 | 0.220 |
Why?
|
| Socioeconomic Factors | 2 | 2015 | 567 | 0.220 |
Why?
|
| Food | 2 | 2022 | 86 | 0.220 |
Why?
|
| Vocabulary, Controlled | 1 | 2022 | 13 | 0.210 |
Why?
|
| Albuterol | 1 | 2022 | 35 | 0.210 |
Why?
|
| Male | 15 | 2019 | 40966 | 0.210 |
Why?
|
| Food Assistance | 1 | 2021 | 2 | 0.210 |
Why?
|
| Early Diagnosis | 1 | 2022 | 131 | 0.210 |
Why?
|
| Data Collection | 1 | 2023 | 372 | 0.200 |
Why?
|
| Kansas | 3 | 2016 | 6 | 0.200 |
Why?
|
| Immunologic Factors | 1 | 2022 | 170 | 0.190 |
Why?
|
| Case-Control Studies | 2 | 2017 | 1805 | 0.190 |
Why?
|
| Terminology as Topic | 2 | 2018 | 217 | 0.190 |
Why?
|
| Machine Learning | 1 | 2022 | 232 | 0.190 |
Why?
|
| Prevalence | 2 | 2014 | 1239 | 0.180 |
Why?
|
| Respiratory Sounds | 1 | 2020 | 33 | 0.180 |
Why?
|
| Journal Impact Factor | 1 | 2019 | 15 | 0.180 |
Why?
|
| Egg Proteins, Dietary | 1 | 2019 | 1 | 0.180 |
Why?
|
| Adolescent | 10 | 2020 | 8981 | 0.180 |
Why?
|
| Virus Diseases | 1 | 2020 | 97 | 0.170 |
Why?
|
| Allergists | 1 | 2018 | 4 | 0.170 |
Why?
|
| Prebiotics | 1 | 2018 | 6 | 0.170 |
Why?
|
| Respiratory Tract Infections | 1 | 2020 | 105 | 0.170 |
Why?
|
| Fatty Acids, Volatile | 1 | 2018 | 32 | 0.170 |
Why?
|
| Infant | 5 | 2023 | 3047 | 0.170 |
Why?
|
| Plant Proteins | 1 | 2018 | 132 | 0.160 |
Why?
|
| Collagen Type V | 1 | 2017 | 2 | 0.160 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 2017 | 8 | 0.160 |
Why?
|
| Skin Abnormalities | 1 | 2017 | 11 | 0.160 |
Why?
|
| Probiotics | 1 | 2018 | 81 | 0.150 |
Why?
|
| Eye Abnormalities | 1 | 2017 | 41 | 0.150 |
Why?
|
| Cross Reactions | 1 | 2017 | 106 | 0.150 |
Why?
|
| Public Health Surveillance | 1 | 2016 | 21 | 0.140 |
Why?
|
| Joint Instability | 1 | 2017 | 81 | 0.140 |
Why?
|
| Biological Products | 1 | 2018 | 143 | 0.140 |
Why?
|
| Disease Progression | 2 | 2020 | 1531 | 0.140 |
Why?
|
| Odds Ratio | 2 | 2014 | 678 | 0.140 |
Why?
|
| Protein Array Analysis | 1 | 2015 | 50 | 0.140 |
Why?
|
| Genes, Bacterial | 1 | 2015 | 198 | 0.130 |
Why?
|
| Health Policy | 1 | 2016 | 180 | 0.130 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2015 | 241 | 0.130 |
Why?
|
| STAT3 Transcription Factor | 1 | 2014 | 78 | 0.120 |
Why?
|
| Pilot Projects | 1 | 2017 | 839 | 0.120 |
Why?
|
| Urban Population | 1 | 2015 | 213 | 0.120 |
Why?
|
| Fish Oils | 1 | 2014 | 11 | 0.120 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2014 | 107 | 0.120 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 508 | 0.120 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2014 | 101 | 0.120 |
Why?
|
| Docosahexaenoic Acids | 1 | 2014 | 31 | 0.120 |
Why?
|
| Antigens, Dermatophagoides | 2 | 2013 | 11 | 0.120 |
Why?
|
| Immunoglobulin E | 1 | 2013 | 144 | 0.110 |
Why?
|
| Food Contamination | 1 | 2012 | 31 | 0.110 |
Why?
|
| Immune System | 1 | 2013 | 93 | 0.110 |
Why?
|
| Disease Reservoirs | 1 | 2012 | 22 | 0.110 |
Why?
|
| Autoimmune Diseases | 1 | 2014 | 241 | 0.110 |
Why?
|
| Risk | 1 | 2014 | 674 | 0.110 |
Why?
|
| DNA Methylation | 1 | 2016 | 628 | 0.100 |
Why?
|
| Complement C1 Inactivator Proteins | 1 | 2011 | 1 | 0.100 |
Why?
|
| Angioedemas, Hereditary | 1 | 2011 | 2 | 0.100 |
Why?
|
| Complement C4 | 1 | 2011 | 10 | 0.100 |
Why?
|
| Urticaria | 1 | 2011 | 10 | 0.100 |
Why?
|
| Air Pollutants | 1 | 2013 | 78 | 0.100 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 853 | 0.100 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2014 | 456 | 0.100 |
Why?
|
| Genetic Testing | 1 | 2014 | 535 | 0.090 |
Why?
|
| Phylogeny | 1 | 2015 | 1137 | 0.090 |
Why?
|
| Environmental Restoration and Remediation | 1 | 2009 | 6 | 0.090 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 865 | 0.090 |
Why?
|
| Animals | 5 | 2020 | 26582 | 0.090 |
Why?
|
| Health Maintenance Organizations | 1 | 2009 | 20 | 0.090 |
Why?
|
| Family Practice | 1 | 2009 | 84 | 0.080 |
Why?
|
| Pregnancy | 1 | 2014 | 2894 | 0.070 |
Why?
|
| Patient Education as Topic | 3 | 2020 | 351 | 0.070 |
Why?
|
| Electric Countershock | 1 | 2006 | 47 | 0.070 |
Why?
|
| Ventricular Fibrillation | 1 | 2006 | 65 | 0.070 |
Why?
|
| Bezoars | 1 | 2005 | 4 | 0.070 |
Why?
|
| Rubber | 1 | 2005 | 6 | 0.070 |
Why?
|
| Pica | 1 | 2005 | 14 | 0.070 |
Why?
|
| Tachycardia, Ventricular | 1 | 2006 | 115 | 0.070 |
Why?
|
| Intestinal Obstruction | 1 | 2005 | 88 | 0.060 |
Why?
|
| Defibrillators, Implantable | 1 | 2006 | 129 | 0.060 |
Why?
|
| Administration, Topical | 1 | 2023 | 95 | 0.060 |
Why?
|
| Administration, Cutaneous | 1 | 2023 | 58 | 0.060 |
Why?
|
| Renal Dialysis | 1 | 2006 | 355 | 0.060 |
Why?
|
| Databases as Topic | 1 | 2023 | 92 | 0.060 |
Why?
|
| Steroids | 1 | 2023 | 177 | 0.050 |
Why?
|
| Iowa | 1 | 2022 | 35 | 0.050 |
Why?
|
| Prescriptions | 1 | 2022 | 21 | 0.050 |
Why?
|
| Information Dissemination | 1 | 2023 | 103 | 0.050 |
Why?
|
| Mucous Membrane | 1 | 2021 | 83 | 0.050 |
Why?
|
| Kidney Failure, Chronic | 1 | 2006 | 509 | 0.050 |
Why?
|
| Genome, Viral | 1 | 2020 | 74 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2008 | 2271 | 0.040 |
Why?
|
| United States Food and Drug Administration | 1 | 2020 | 127 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2022 | 379 | 0.040 |
Why?
|
| Primary Prevention | 1 | 2020 | 85 | 0.040 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2018 | 42 | 0.040 |
Why?
|
| Adult | 7 | 2018 | 25648 | 0.040 |
Why?
|
| Maximum Tolerated Dose | 1 | 2018 | 270 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2020 | 257 | 0.040 |
Why?
|
| beta-Thalassemia | 1 | 1997 | 6 | 0.040 |
Why?
|
| Joints | 1 | 2017 | 32 | 0.040 |
Why?
|
| Gastrointestinal Diseases | 1 | 2018 | 146 | 0.040 |
Why?
|
| Interferon-alpha | 1 | 1997 | 233 | 0.040 |
Why?
|
| Face | 1 | 2017 | 114 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2017 | 270 | 0.040 |
Why?
|
| Social Class | 1 | 2016 | 128 | 0.040 |
Why?
|
| Risk Factors | 3 | 2014 | 5417 | 0.030 |
Why?
|
| Young Adult | 2 | 2018 | 5976 | 0.030 |
Why?
|
| Hepatitis C | 1 | 1997 | 208 | 0.030 |
Why?
|
| STAT5 Transcription Factor | 1 | 2014 | 42 | 0.030 |
Why?
|
| Mutation | 2 | 2017 | 3968 | 0.030 |
Why?
|
| STAT1 Transcription Factor | 1 | 2014 | 52 | 0.030 |
Why?
|
| Missouri | 1 | 2014 | 19 | 0.030 |
Why?
|
| Genes, rRNA | 1 | 2014 | 7 | 0.030 |
Why?
|
| Genes, Fungal | 1 | 2014 | 58 | 0.030 |
Why?
|
| Exome | 1 | 2014 | 127 | 0.030 |
Why?
|
| Age Factors | 1 | 2018 | 1851 | 0.030 |
Why?
|
| Cities | 1 | 2014 | 40 | 0.030 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2020 | 455 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2014 | 476 | 0.030 |
Why?
|
| Arthropod Proteins | 1 | 2013 | 8 | 0.030 |
Why?
|
| United States Environmental Protection Agency | 1 | 2012 | 5 | 0.030 |
Why?
|
| Gene Expression | 1 | 2017 | 1284 | 0.030 |
Why?
|
| Cysteine Endopeptidases | 1 | 2013 | 87 | 0.030 |
Why?
|
| DNA, Fungal | 1 | 2012 | 57 | 0.030 |
Why?
|
| Middle Aged | 4 | 2018 | 25028 | 0.030 |
Why?
|
| Fungal Proteins | 1 | 2013 | 141 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2014 | 217 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2014 | 1106 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2014 | 295 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 1036 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 1801 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2009 | 3640 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 2767 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 927 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 860 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 1565 | 0.020 |
Why?
|
| Air Conditioning | 1 | 2009 | 6 | 0.020 |
Why?
|
| Genome, Human | 1 | 2014 | 756 | 0.020 |
Why?
|
| Colony Count, Microbial | 1 | 2009 | 46 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2009 | 153 | 0.020 |
Why?
|
| Comparative Effectiveness Research | 1 | 2009 | 53 | 0.020 |
Why?
|
| Insurance, Health | 1 | 2009 | 160 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2009 | 174 | 0.020 |
Why?
|
| Health Care Costs | 1 | 2009 | 238 | 0.020 |
Why?
|
| Interior Design and Furnishings | 1 | 2005 | 1 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2014 | 2357 | 0.020 |
Why?
|
| Registries | 1 | 2009 | 702 | 0.020 |
Why?
|
| Illinois | 1 | 2006 | 462 | 0.020 |
Why?
|
| Boutonneuse Fever | 1 | 1983 | 1 | 0.010 |
Why?
|
| Rickettsiaceae Infections | 1 | 1983 | 2 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1983 | 68 | 0.010 |
Why?
|
| Survival Rate | 1 | 2006 | 1863 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2009 | 2261 | 0.010 |
Why?
|
| Prognosis | 2 | 2006 | 3679 | 0.010 |
Why?
|
| Siderosis | 1 | 1997 | 2 | 0.010 |
Why?
|
| Alanine Transaminase | 1 | 1997 | 73 | 0.010 |
Why?
|
| Iron | 1 | 1997 | 164 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2006 | 6509 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1997 | 1014 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 1997 | 999 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1997 | 971 | 0.010 |
Why?
|
| Liver | 1 | 1997 | 1230 | 0.010 |
Why?
|
| Aged | 2 | 2006 | 18415 | 0.010 |
Why?
|
| Time Factors | 1 | 1997 | 5210 | 0.010 |
Why?
|